Psychodynamic Therapy
Psychodynamic Therapy (Psychoanalytic Psychotherapy)
Evidence grade varies by use. See the breakdown on the entry. Read how the Atlas grades evidence.
Evidence is real but uneven, and the honest reading is emerging-to-moderate human data rather than top-tier proof. For short-term psychodynamic psychotherapy (STPP) in depression and anxiety, multiple randomized trials and meta-analyses report benefit over wait-list and minimal-treatment controls, with effects broadly comparable to other active therapies; recent reviews conclude STPP is effective for depression and is consistent with NICE guidance, though it does not clearly beat CBT and may be slightly less effective than antidepressants in some comparisons. Shedler's widely cited 2010 review reported a large overall effect (around 0.97 for general symptoms) and gains that may grow after therapy ends, but critics counter that he overstated study quality, pooled clinically dissimilar trials, and underplayed contrary findings. Evidence for long-term psychodynamic therapy in complex and personality disorders is weaker and more disputed, resting on a small number of comparative trials. Psychodynamically derived treatments for borderline personality disorder (mentalization-based treatment, transference-focused psychotherapy) have their own RCT support. Overall grade 3, with the depression indication firmer than the long-term/personality claims.
Reference only. Not medical advice.
| Treatment | Grade | Notes |
|---|---|---|
| Depression (short-term, STPP) | 3 of 5 | Multiple RCTs and meta-analyses show benefit over controls and rough parity with CBT; NICE-consistent. Firmest indication, but not clearly superior to other active treatments and possibly below antidepressants in some trials. |
| Anxiety disorders (short-term) | 3 of 5 | Several trials support STPP for common anxiety disorders, with effects broadly comparable to other psychotherapies. Fewer and smaller trials than for depression. |
| Borderline personality disorder (MBT, TFP) | 3 of 5 | Mentalization-based and transference-focused treatments have dedicated RCTs showing reduced self-harm and symptom burden. Promising but trial bases are modest and largely from specialist centers. |
| Long-term therapy for complex/chronic disorders | 2 of 5 | Leichsenring and Rabung reported large effects, but conclusions rest on few comparative trials with pooled, clinically variable outcomes; replication and methodology are openly disputed. |
What can go wrong
Generally low physical risk. The main concerns are opportunity cost and fit: long courses can be lengthy and expensive, and for acute conditions needing structured or medical management (active suicidality, severe eating behavior, substance use disorders, psychosis), psychodynamic work alone may delay more appropriate or urgent care. Exploratory therapy can transiently intensify distress as difficult material surfaces. Quality and training vary widely, and "psychodynamic" is not a protected or standardized label. Anyone in crisis or facing self-harm, disordered eating, or addiction should be connected to appropriate clinical care rather than relying on this entry.
This is something to take to a clinician. The Atlas can tell you what is known about psychodynamic therapy in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Psychodynamic therapy is the broad family of talk therapies descended from psychoanalysis, sharing the premise that current symptoms and relationship patterns are shaped by unconscious conflict, early experience, and defenses against painful feeling. Unlike the years-on-the-couch caricature, most contemporary practice is once or twice weekly and often time-limited. After decades of being treated as the unscientific opposite of cognitive behavioral therapy, it now has a genuine if imperfect evidence base: randomized trials and meta-analyses support short-term forms for depression and anxiety at roughly the level of other active treatments, and psychodynamically rooted methods have specific support in borderline personality disorder. The catch is that the strongest claims, very large effects and benefits that keep growing after therapy ends, come from reviews that critics say overstate study quality. The clinical finding (it helps many people) is on firmer ground than the mechanistic theory (that uncovering the unconscious is what does the work). Both deserve to be weighed on their own.
A talk therapy that treats present symptoms as echoes of unconscious conflict and early relationships, long dismissed as untestable and now backed by a respectable, if contested, body of trial evidence.
How it is supposed to work
Established mechanism is uncertain and shared with most talk therapies. The best supported common factors are the therapeutic alliance, a coherent treatment frame, and structured emotional processing, none of them unique to psychodynamic work. The distinctive proposed mechanisms are psychodynamic theory, not settled fact: that symptoms express unconscious conflict, that early relationships set templates ("internal working models") replayed in adult life, that defenses keep painful material out of awareness, and that examining how these patterns surface in the therapy relationship itself (transference) produces lasting change. Proponents describe seven hallmarks (focus on emotion, exploring avoidance, recurring themes, the past, relationships, the therapy relationship, and fantasy life). Whether insight into the unconscious is the active ingredient, or whether benefit comes from generic factors, remains contested.
What people get wrong
Often saidPsychodynamic therapy is unscientific and has no evidence behind it.
ActuallyRandomized trials and meta-analyses support short-term forms for depression and anxiety at roughly the level of other active treatments; the dispute is over how large the effects are, not whether any exist.
Often saidIt always means years of lying on a couch several times a week.
ActuallyMost contemporary practice is once or twice weekly and face to face, and many evidence-tested versions are deliberately short-term, around 40 sessions or fewer.
Who profits, and who pushes back
Jonathan Shedler, PhD
Shedler argues that effect sizes for psychodynamic therapy are as large as those for treatments actively promoted as evidence based, and that dismissal reflects bias more than data.
Methodological critics, American Psychologist (2011)
They contend the favorable reviews overstate study quality, pool dissimilar trials, and ignore counter-evidence, so the headline effects may not hold up in ordinary clinical practice.
NICE-aligned clinical reviewers
Recent reviews conclude short-term psychodynamic therapy is effective for depression and consistent with NICE guidance, while noting it does not clearly outperform CBT.
Private psychodynamic training institutes and clinics
Sells this. Has a commercial interest in a product sold as this compound, as of July 2026.
Institutes describe long-term depth work as uniquely transformative for complex cases, a claim that rests on a thinner and more disputed trial base than the short-term depression evidence.
Where the research comes from
Most of the published research on this comes from one place. 85% of it is from Europe (esp. Germany, UK, Scandinavia). Findings that no unrelated group has reproduced are weaker than the study count makes them look.
| Place | Share of published research |
|---|---|
| Europe (esp. Germany, UK, Scandinavia) | 85% |
| South America (esp. Argentina, Brazil) | 80% |
| North America | 70% |
| Australia & New Zealand | 45% |
| East Asia | 35% |
How we got here
Structured attention to dreams, hidden motives, and inner conflict predates Freud by millennia. Sumerian and Babylonian dream interpreters in Mesopotamia recorded dream omens on clay from at least the third millennium BCE, and Egyptian priests kept dream dictionaries treating dreams as messages requiring decoding. Greek temple medicine practiced "incubation," sleeping in a sacred space to receive a guiding dream, while physicians such as Hippocrates linked dreams to bodily and emotional states. Chinese, Korean, and Japanese traditions read conception dreams (taemong) as signs of a child's character and destiny, and classical Indian and Buddhist thought developed detailed maps of mind, craving, and the layers beneath ordinary awareness. Sigmund Freud in Vienna around 1900 reworked these inherited intuitions into a clinical method, casting dreams and slips as routes to a dynamic unconscious, and his successors (Jung, Klein, Winnicott, Bowlby, Kohut) reshaped it for more than a century.
The raw materials predate Freud by thousands of years and are global: Mesopotamian and Egyptian dream specialists, Greek dream incubation and Hippocratic links between dreams and health, East Asian conception-dream traditions, and Indian and Buddhist analyses of mind and craving. Sigmund Freud in Vienna formalized these into psychoanalysis around 1900, with The Interpretation of Dreams in 1899/1900 as a landmark. The twentieth century saw repeated revisions: Jung's analytical psychology, Klein and the object-relations school, Winnicott, Bowlby's attachment theory, and Kohut's self psychology, spreading through Europe and the Americas. From the 1960s onward, behavioral and cognitive therapies challenged psychoanalysis as untestable, and managed care favored shorter, manualized treatments, pushing psychodynamic work to the margins of academic psychology. From the 2000s, brief manualized forms and meta-analyses (Leichsenring, Shedler, and others) staged a partial empirical rehabilitation, alongside dedicated trials of mentalization-based and transference-focused treatments for personality disorders.
- ~3000 BCEMesopotamian and Egyptian dream specialists record dream omens and dictionaries, treating dreams as decodable messages
- 1899/1900Freud publishes The Interpretation of Dreams, anchoring psychoanalysis in the idea of a dynamic unconscious
- 1960s-1990sBehavioral and cognitive therapies and managed care push psychoanalysis to the margins as untestable and slow
- 2008-2011Leichsenring/Rabung and Shedler reviews report strong effects; published critics dispute the methodology in American Psychologist
- 2020sUpdated meta-analyses and RCTs (including for borderline personality disorder) refine the evidence; STPP is treated as consistent with NICE guidance for depression
How it is understood
Insight into dreams and hidden motive is one of the most widely distributed human practices, appearing independently across Mesopotamian, Egyptian, Greek, Indian, Chinese, and many Indigenous traditions long before it was medicalized. Freud's specific theoretical apparatus is a European product of its time and place, and parts of it carry the cultural assumptions of late nineteenth century Vienna. Psychodynamic therapy today is a secular, professionalized descendant rather than the property of any single living tradition, so commercialization questions are limited, though clinicians increasingly note that older insight and dream traditions deserve naming rather than being folded silently into a Freudian origin story.
Where scholars disagree
There is a genuine, published dispute over how strong the evidence for psychodynamic therapy actually is, centered on whether influential reviews reported reliable effects or overstated a weak base.
Jonathan Shedler and proponents of psychodynamic efficacy
Shedler reports that effect sizes for psychodynamic therapies are as large as those for treatments promoted as empirically supported, with an overall short-term effect near 0.97 and gains that may continue to grow after therapy ends, and attributes dismissal to lingering bias against psychoanalysis.
What it rests onShedler, 'The Efficacy of Psychodynamic Psychotherapy,' American Psychologist 65(2), 2010; supporting meta-analyses on STPP for depression and on long-term psychodynamic therapy (Leichsenring and Rabung).
Methodological critics (e.g. responses in American Psychologist, 2011)
Critics argue the reviews gloss over methodological details, pool clinically variable trials, ignore findings that run counter to the favorable conclusion, and overstate the quality and quantity of the evidence, so the large effects may not replicate in routine practice.
What it rests onPublished critiques including 'Is There Room for Criticism of Studies of Psychodynamic Psychotherapy?' and 'When It Comes to Evaluating Psychodynamic Therapy, the Devil Is in the Details,' American Psychologist, 2011.
At a glance
- Oldest antecedents
- Mesopotamian and Egyptian dream interpreters, third millennium BCE and earlier
- Founder / date
- Sigmund Freud, Vienna, psychoanalysis formalized around 1900
- Typical modern format
- Once or twice weekly talk therapy; many forms are time-limited, not open-ended
- Best-supported indication
- Short-term forms for depression and anxiety, broadly comparable to other active therapies
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Psychodynamic Therapy. A short entry is not a safe entry.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- What people take it for. We have not catalogued the claims made for it.
Sources
No sources recorded for this entry yet. Nothing on this page can be checked against a citation until that changes, so treat it as a summary awaiting its evidence.